Curcumin for Maintenance Therapy in Ulcerative Colitis

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 5, 2007, Pages 642-

  Moss, Alan C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; MESALAZINE; SALAZOSULFAPYRIDINE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; DEMOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LETTER; MAINTENANCE THERAPY; NONHUMAN; ODOR; TASTE; ULCERATIVE COLITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIAS (EPIDEMIOLOGY); COLITIS, ULCERATIVE; CURCUMIN; HUMANS; MESALAMINE; TREATMENT OUTCOME;

EID: 34247523216     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2007.03.002     Document Type: Letter

References (4)

1. Hanai H., Lida T., Takeuchi K., et al. Curcumin maintenance therapy for ulcerative colitis: randomized multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 4 (2006) 1502-1506
2. Sharma R.A., Gescher A.J., and Steward W.P. Curcumin: the story so far. Eur J Cancer 41 (2005) 1955-1968
3. Sutherland L., and Macdonald J.K. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev 2 (2006) CD000544
4. Azad Khan A.K., Howes D.T., Piris J., et al. Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 21 (1980) 232-240